GJC2 and myeloid sarcoma: In fact, our results align with studies conducted on human multiple sclerosis (MS) brains, where newly differentiated OLs may exhibit Cx47 GJ expression, while the presence of Cx47 in mature OLs is consistently absent in chronic MS plaques [27, 29].